News & Events

News

All categories

Earnings

Press Release

All years

2019

2018

2017

2016

2015

2014

Affimed Presents Additional Data on Combination of AFM13 with Checkpoint Inhibitors at ASH

December 6, 2015

Affimed Presents Data Comparing T-cell- and NK-cell- engaging TandAbs AFM11 and AFM12 at ASH

December 6, 2015

Affimed Announces Appointment of Andrew Curtis to Lead Corporate Strategy and Business Development, Expansion of US Presence

December 2, 2015

Affimed to Present at the Oppenheimer 26th Annual Healthcare Conference –New York

December 1, 2015

Affimed CEO to Present at the Jefferies 2015 Global Healthcare Conference – London

November 11, 2015

Affimed Reports Financial Results for Third Quarter 2015

November 10, 2015

Affimed Presents Data on Potency of NK- and T-cell EGFRvIII TandAbs at SITC

November 6, 2015

Affimed to Present Data on NK- and T-Cell Engagers at ASH

November 5, 2015

Affimed Announces Third Quarter 2015 Financial Results and Corporate Update Conference Call

November 3, 2015

Affimed Announces Significant Investment by an Existing Shareholder

October 14, 2015

Events

All

Scientific

Investors

There are no events planned at the moment.

Webcasts
More events

We use cookies to give you the best experience on our website. By continuing to use it, you agree with it.